ArticleEuropean heart journal open2025
Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65: the PROOF-AF study.
Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Heart rate fragmentation as a marker of autonomic function in healthy young individuals: insights from graded head-up tilt test and controlled breathing.Frontiers in physiology · 2026Article
- Association between heart rate fragmentation and kidney function decline in MESA: evidence consistent with parasympathetic degradation.American journal of physiology. Regulatory, integrative and comparative physiology · 2025Article
- Vagal impairment and cardiovascular risk in those with zero to low coronary artery calcification scores: the Multi-Ethnic Study of Atherosclerosis.American journal of physiology. Heart and circulatory physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Screening the general population aged 65 for atrial fibrillation (AF) has been proposed as a preventive measure against potential complications. Metrics derived from heart rate variability (HRV) that depict heart rate fragmentation (HRF) have been suggested to reflect autonomic nervous system dysfunction. The aim of the study was to assess the predictive capacity of HRV markers, including HRF, for AF occurrence over an 18-year follow-up and to develop a predictive score for AF onset among the general population aged 65 at the study's inception. Methods and results: The PROOF prospective cohort consisted of 1011 subjects aged 65 with no history of AF nor history of cardiovascular disease. A 24 h Holter-electrocardiogram was performed at baseline and HRV, from which HRV indices using temporal, frequency, and non-linear methods, and the percentage of inflection points (PIPs) were calculated. The PROOF cohort demonstrated a cumulative incidence of AF of 13.0% during a median follow-up of 17.8 years. Male gender, hypertension, decreased heart rate and α1, and increased premature atrial complex burden, PNN50, and PIP were independent predictors of AF occurrence. Subsequently, the PROOF-AF risk score was developed, ranging from 0 to 7, providing interesting predictive capacity [area under the curve (AUC) = 70.1%, negative predictive value = 92.0%, and accuracy = 72.0%]. The high-risk group (PROOF-AF score from 5 to 7) and the intermediate-risk group (PROOF-AF score from 2 to 4) exhibited a 16.8- and 5.4-fold higher risk, respectively, of developing AF. Conclusion: Heart rate fragmentation parameters, included in the PROOF-AF score, may be used to identify healthy individuals aged 65 who are at high risk of developing AF and assist population screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.